INTRODUCTION: Pregnant women often underreport their smoking status and extent of secondhand smoke (SHS) exposure. Biomarker confirmation is the recommended method to assess smoking behaviors and SHS exposure in both mothers and infants. OBJECTIVES: The primary aims are to (a) examine the relationship between smoking behaviors and SHS exposure in mother-baby couplets using maternal and infant hair nicotine and maternal urine cotinine analyses and (b) determine whether there is an association between maternal and infant hair nicotine samples obtained shortly after birth. DISCUSSION: A cross-sectional study with a multiethnic sample of 210 mother-baby couplets assessing SHS exposure. RESULTS: The level of maternal hair nicotine (MHN) was significantly different among three groups: nonsmoking, nonsmoking/passive exposed, and smoking (p < .0001), with nonsmoking and nonexposed women having the lowest level. Urine cotinine was strongly associated with self-reported smoking status (rho = .88; p < .0001). Maternal and infant hair nicotine were correlated, although MHN correlated more strongly with smoking status (rho = .46, p < .0001) than infant hair nicotine (rho = .39, p < .0001). CONCLUSIONS: MHN was a more precise biomarker of prenatal SHS exposure than infant hair nicotine; mothers' urine cotinine was strongly correlated with self-reported smoking status.
INTRODUCTION: Pregnant women often underreport their smoking status and extent of secondhand smoke (SHS) exposure. Biomarker confirmation is the recommended method to assess smoking behaviors and SHS exposure in both mothers and infants. OBJECTIVES: The primary aims are to (a) examine the relationship between smoking behaviors and SHS exposure in mother-baby couplets using maternal and infant hair nicotine and maternal urine cotinine analyses and (b) determine whether there is an association between maternal and infant hair nicotine samples obtained shortly after birth. DISCUSSION: A cross-sectional study with a multiethnic sample of 210 mother-baby couplets assessing SHS exposure. RESULTS: The level of maternal hair nicotine (MHN) was significantly different among three groups: nonsmoking, nonsmoking/passive exposed, and smoking (p < .0001), with nonsmoking and nonexposed women having the lowest level. Urine cotinine was strongly associated with self-reported smoking status (rho = .88; p < .0001). Maternal and infant hair nicotine were correlated, although MHN correlated more strongly with smoking status (rho = .46, p < .0001) than infant hair nicotine (rho = .39, p < .0001). CONCLUSIONS:MHN was a more precise biomarker of prenatal SHS exposure than infant hair nicotine; mothers' urine cotinine was strongly correlated with self-reported smoking status.
Authors: Farla Lynn Kaufman; Martin Kharrazi; Gerald Nicholas Delorenze; Brenda Eskenazi; John Thomas Bernert Journal: J Expo Anal Environ Epidemiol Date: 2002-07
Authors: Kristin B Ashford; Ellen Hahn; Lynne Hall; Mary Kay Rayens; Melody Noland; James E Ferguson Journal: J Obstet Gynecol Neonatal Nurs Date: 2010 Sep-Oct
Authors: Kristin Ashford; Emily Rayens; Amanda T Wiggins; Mary Kay Rayens; Amanda Fallin; Molly Malany Sayre Journal: Public Health Nurs Date: 2017-05-09 Impact factor: 1.462
Authors: Michal Bitan; David M Steinberg; Sandra R Wilson; Amy E Kalkbrenner; Bruce Lanphear; Melbourne F Hovell; Vicki Myers Gamliel; Laura J Rosen Journal: Tob Induc Dis Date: 2022-06-29 Impact factor: 5.163
Authors: Nerea Mourino; Mónica Pérez-Ríos; Maria Isolina Santiago-Pérez; Bruce Lanphear; Kimberly Yolton; Joseph M Braun Journal: BMJ Open Date: 2021-06-28 Impact factor: 2.692